UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations

Clinical infectious diseases, 2017-12, Vol.65 (11), p.1780-1789

2017

Volltextzugriff (PDF)

Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden

The European respiratory journal, 2016-04, Vol.47 (4), p.1208-1218

2016

Volltextzugriff (PDF)

Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences

Proceedings of the National Academy of Sciences - PNAS, 2014-04, Vol.111 (17), p.E1768-E1776

2014

Volltextzugriff (PDF)

Epidemiology of Severe Streptococcus pyogenes Disease in Europe

Journal of Clinical Microbiology, 2008-07, Vol.46 (7), p.2359-2367

2008

Volltextzugriff (PDF)

Clinical and Microbiological Characteristics of Severe Streptococcus pyogenes Disease in Europe

Journal of Clinical Microbiology, 2009-04, Vol.47 (4), p.1155-1165

2009

Volltextzugriff (PDF)

Intravenous Immunoglobulin G Therapy in Streptococcal Toxic Shock Syndrome: A European Randomized, Double-Blind, Placebo-Controlled Trial

Clinical infectious diseases, 2003-08, Vol.37 (3), p.333-340

2003

Volltextzugriff (PDF)

Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?

PloS one, 2016-11, Vol.11 (11), p.e0166018-e0166018

2016

Volltextzugriff (PDF)

Molecular and Clinical Characteristics of Invasive Group A Streptococcal Infection in Sweden

Clinical infectious diseases, 2007-08, Vol.45 (4), p.450-458

2007

Volltextzugriff (PDF)

Differences in Potency of Intravenous Polyspecific Immunoglobulin G against Streptococcal and Staphylococcal Superantigens: Implications for Therapy of Toxic Shock Syndrome

Clinical infectious diseases, 2004-03, Vol.38 (6), p.836-842

2004

Volltextzugriff (PDF)

Bacterial phenotype variants in group B streptococcal toxic shock syndrome

Emerging infectious diseases, 2009-02, Vol.15 (2), p.223-232

2009

Volltextzugriff (PDF)

Variations in emm Type among Group A Streptococcal Isolates Causing Invasive or Noninvasive Infections in a Nationwide Study

Journal of Clinical Microbiology, 2005-07, Vol.43 (7), p.3101-3109

2005

Volltextzugriff (PDF)

Clinical Efficacy of Polyspecific Intravenous Immunoglobulin Therapy in Patients With Streptococcal Toxic Shock Syndrome: A Comparative Observational Study

Clinical infectious diseases, 2014-09, Vol.59 (6), p.851-857

2014

Volltextzugriff (PDF)

A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development

The Journal of infectious diseases, 2014-10, Vol.210 (8), p.1325-1338

2014

Volltextzugriff (PDF)

Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia

Thorax, 2013-06, Vol.68 (6), p.571-579

2013

Volltextzugriff (PDF)

Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8 years after vaccine introduction in Stockholm, Sweden

Vaccine, 2016-08, Vol.34 (38), p.4565-4571

2016

Volltextzugriff (PDF)

Reduced In Vitro Susceptibility of Streptococcus pyogenes to β-Lactam Antibiotics Associated with Mutations in the pbp2x Gene Is Geographically Widespread

Journal of clinical microbiology, 2020-03, Vol.58 (4)

2020

Volltextzugriff (PDF)

Reply to Theilacker et al

Clinical infectious diseases, 2018-05, Vol.66 (10), p.1642-1643

2018

Volltextzugriff (PDF)

Bacterial Phenotype Variants in Group B Streptococcal Toxic Shock Syndrome1

Emerging infectious diseases, 2009-02, Vol.15 (2), p.223-232

2009

Volltextzugriff (PDF)

Global spatial dynamics and vaccine-induced fitness changes of Bordetella pertussis

Science translational medicine, 2022-04, Vol.14 (642), p.eabn3253

2022

Volltextzugriff (PDF)

Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types

The European respiratory journal, 2014-12, Vol.44 (6), p.1646-1657

2014

Volltextzugriff (PDF)

Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study

Clinical microbiology and infection, 2013-05, Vol.19 (5), p.E222-E229

2013

Volltextzugriff (PDF)

Efficacy of Polyspecific Intravenous Immunoglobulin Therapy in Streptococcal Toxic Shock Syndrome Reply

Clinical infectious diseases, 2015-01, Vol.60 (2)

2015

Volltextzugriff (PDF)

Reply to Arends and Harkisoen

Clinical infectious diseases, 2015-01, Vol.60 (2), p.324-325

2015

Volltextzugriff (PDF)

Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden

Vaccine, 2016-08, Vol.34 (38), p.4565-4571

2016

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(36)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations

Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden

Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences

Epidemiology of Severe Streptococcus pyogenes Disease in Europe

Clinical and Microbiological Characteristics of Severe Streptococcus pyogenes Disease in Europe

Intravenous Immunoglobulin G Therapy in Streptococcal Toxic Shock Syndrome: A European Randomized, Double-Blind, Placebo-Controlled Trial

Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?

Molecular and Clinical Characteristics of Invasive Group A Streptococcal Infection in Sweden

Differences in Potency of Intravenous Polyspecific Immunoglobulin G against Streptococcal and Staphylococcal Superantigens: Implications for Therapy of Toxic Shock Syndrome

Bacterial phenotype variants in group B streptococcal toxic shock syndrome

Variations in emm Type among Group A Streptococcal Isolates Causing Invasive or Noninvasive Infections in a Nationwide Study

Clinical Efficacy of Polyspecific Intravenous Immunoglobulin Therapy in Patients With Streptococcal Toxic Shock Syndrome: A Comparative Observational Study

A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development

Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination

Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia

Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8 years after vaccine introduction in Stockholm, Sweden

Reduced In Vitro Susceptibility of Streptococcus pyogenes to β-Lactam Antibiotics Associated with Mutations in the pbp2x Gene Is Geographically Widespread

Reply to Theilacker et al

Bacterial Phenotype Variants in Group B Streptococcal Toxic Shock Syndrome1

Global spatial dynamics and vaccine-induced fitness changes of Bordetella pertussis

Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types

Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study

Efficacy of Polyspecific Intravenous Immunoglobulin Therapy in Streptococcal Toxic Shock Syndrome Reply

Reply to Arends and Harkisoen

Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden

Suchergebnisse filtern